• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾移植等待名单的资格:一种将患者风险概念化的模型。

Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk.

作者信息

Kiberd Bryce A, Tennankore Karthik K, West Kenneth

机构信息

Division of Nephrology, Department of Medicine, Dalhousie University, Room 5082 Dickson Building, Queen Elizabeth II HSC-VG site, 5280 University Avenue, Halifax B3H 1V8, NS, Canada.

出版信息

Transplant Res. 2014 Jan 8;3(1):2. doi: 10.1186/2047-1440-3-2.

DOI:10.1186/2047-1440-3-2
PMID:24401550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3895784/
Abstract

BACKGROUND

Determining eligibility for a kidney transplant is one of the most important decisions facing nephrologists. It is assumed that the harm of kidney transplantation is minimal and most will benefit. The purpose of this study was to quantify the probability of 'no benefit' as defined by death on the wait list; 'harm', defined by the probability that a transplanted patient would live less than the average wait listed patient; and 'benefit' for the probability a transplanted patient would outlive the average wait listed patient.

METHODS

A computerized model was developed to replicate observed patient survival outcomes in deceased donor kidney transplantation. Three sequential periods of risk for the transplanted recipient compared to the wait listed cohort (increased, equivalent and reduced risk) were modeled.

RESULTS

The model predicted that wait listed patients with a baseline mortality of 28 deaths per 100 patient years were equally likely to benefit or be harmed with a transplant. However if 20% of patients on the wait list were on hold (assuming a 2.2-fold higher mortality than those who were transplanted), then the baseline mortality rate for equal harm or benefit decreases to 22 deaths per 100 patient years (equivalent life expectancy 4.5 years).

CONCLUSION

Patients with limited life expectancies are more likely to suffer some harm than derive benefit from kidney transplantation.

摘要

背景

确定肾移植的合适人选是肾病学家面临的最重要决策之一。一般认为肾移植的危害极小,大多数人会从中受益。本研究的目的是量化按等待名单上死亡定义的“无获益”概率;按移植患者存活时间短于等待名单上患者平均存活时间定义的“危害”概率;以及按移植患者存活时间长于等待名单上患者平均存活时间定义的“获益”概率。

方法

开发了一个计算机模型,以复制已故供体肾移植中观察到的患者生存结果。对移植受者与等待名单队列相比的三个连续风险期(风险增加、风险相当和风险降低)进行了建模。

结果

该模型预测,每100患者年基线死亡率为28例死亡的等待名单上的患者接受移植后获益或受伤害的可能性相同。然而,如果等待名单上20%的患者被搁置(假设死亡率比接受移植的患者高2.2倍),那么同等伤害或获益的基线死亡率降至每100患者年22例死亡(预期寿命4.5年)。

结论

预期寿命有限的患者接受肾移植更有可能遭受一些伤害而非获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/e1d4ec62cebb/2047-1440-3-2-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/23c14de04aca/2047-1440-3-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/2309e2d955b5/2047-1440-3-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/e1d4ec62cebb/2047-1440-3-2-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/23c14de04aca/2047-1440-3-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/2309e2d955b5/2047-1440-3-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f50/3895784/e1d4ec62cebb/2047-1440-3-2-3.jpg

相似文献

1
Eligibility for the kidney transplant wait list: a model for conceptualizing patient risk.肾移植等待名单的资格:一种将患者风险概念化的模型。
Transplant Res. 2014 Jan 8;3(1):2. doi: 10.1186/2047-1440-3-2.
2
Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study.衰弱与肾移植等待名单:一项多中心前瞻性研究方案
Can J Kidney Health Dis. 2020 Sep 10;7:2054358120957430. doi: 10.1177/2054358120957430. eCollection 2020.
3
Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates.等待名单上的候选者的功能状态、移植时间以及肾移植的生存获益
Am J Kidney Dis. 2015 Nov;66(5):837-45. doi: 10.1053/j.ajkd.2015.05.015. Epub 2015 Jul 7.
4
Association Between Declined Offers of Deceased Donor Kidney Allograft and Outcomes in Kidney Transplant Candidates.接受或拒绝已故供体肾移植与肾移植候选人结局的关系。
JAMA Netw Open. 2019 Aug 2;2(8):e1910312. doi: 10.1001/jamanetworkopen.2019.10312.
5
Risk stratification and transplant benefit in children listed for heart transplant in the United States.美国心脏移植名单中儿童的风险分层和移植获益。
Circ Heart Fail. 2013 Jul;6(4):800-8. doi: 10.1161/CIRCHEARTFAILURE.112.000280. Epub 2013 May 23.
6
Poor outcomes for children on the wait list at low-volume kidney transplant centers in the United States.美国低移植量肾脏移植中心等待名单上儿童的不良预后。
Pediatr Nephrol. 2017 Apr;32(4):669-678. doi: 10.1007/s00467-016-3519-x. Epub 2016 Oct 18.
7
Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.对移植等待名单上儿科候选者肝脏供体情况的分析。
Gastroenterology. 2017 Oct;153(4):988-995. doi: 10.1053/j.gastro.2017.06.053. Epub 2017 Jul 13.
8
Panic in the Pandemic: When Should Kidney Transplant Programs Close?大流行中的恐慌:肾脏移植项目何时应关闭?
Kidney Int Rep. 2021 Feb 26;6(5):1232-1241. doi: 10.1016/j.ekir.2021.02.017. eCollection 2021 May.
9
Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.加拿大安大略省透析患者与尸体供肾首次肾移植受者死亡风险的比较。
J Am Soc Nephrol. 2000 May;11(5):917-922. doi: 10.1681/ASN.V115917.
10
Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.终末期肝病模型评分低的肝移植候选者的结局
Liver Transpl. 2015 Nov;21(11):1403-9. doi: 10.1002/lt.24307.

引用本文的文献

1
Low Rates of Preemptive Kidney Transplantation: A Root Cause Analysis to Identify Opportunities for Improvement.低比例的抢先肾移植:一项根本原因分析以确定改进机会。
J Clin Med Res. 2021 Jan;13(1):1-8. doi: 10.14740/jocmr4391. Epub 2021 Jan 12.
2
Frailty and the Kidney Transplant Wait List: Protocol for a Multicenter Prospective Study.衰弱与肾移植等待名单:一项多中心前瞻性研究方案
Can J Kidney Health Dis. 2020 Sep 10;7:2054358120957430. doi: 10.1177/2054358120957430. eCollection 2020.
3
Frailty Screening in Chronic Kidney Disease: Current Perspectives.

本文引用的文献

1
Uncertainty--the other side of prognosis.不确定性——预后的另一面。
N Engl J Med. 2013 Jun 27;368(26):2448-50. doi: 10.1056/NEJMp1303295.
2
Frailty and early hospital readmission after kidney transplantation.肾移植后虚弱与早期医院再入院。
Am J Transplant. 2013 Aug;13(8):2091-5. doi: 10.1111/ajt.12300. Epub 2013 Jun 3.
3
Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis.衰弱作为一个新的预测因素,可以预测所有年龄段接受血液透析个体的死亡率和住院率。
慢性肾脏病中的衰弱筛查:当前观点
Int J Nephrol Renovasc Dis. 2019 Dec 5;12:229-239. doi: 10.2147/IJNRD.S228956. eCollection 2019.
4
Contraindications to kidney transplantation: uneven grounds?肾移植的禁忌证:依据不充分?
Transplant Res. 2015 Jul 21;4:2. doi: 10.1186/s13737-015-0024-x. eCollection 2015.
J Am Geriatr Soc. 2013 Jun;61(6):896-901. doi: 10.1111/jgs.12266. Epub 2013 May 27.
4
Trends in the inactive kidney transplant waitlist and implications for candidate survival.肾脏移植候补者中无活性肾脏的趋势及对候选者生存的影响。
Am J Transplant. 2013 Apr;13(4):1012-1018. doi: 10.1111/ajt.12143. Epub 2013 Feb 7.
5
Quantification of the early risk of death in elderly kidney transplant recipients.老年肾移植受者早期死亡风险的量化。
Am J Transplant. 2013 Feb;13(2):427-32. doi: 10.1111/j.1600-6143.2012.04323.x. Epub 2012 Nov 21.
6
Clinical practice guidelines on wait-listing for kidney transplantation: consistent and equitable?肾脏移植等候名单的临床实践指南:一致且公平?
Transplantation. 2012 Oct 15;94(7):703-13. doi: 10.1097/TP.0b013e3182637078.
7
Gompertz' survivorship law as an intrinsic principle of aging.戈梅茨生存定律是衰老的内在原则。
Med Hypotheses. 2012 May;78(5):659-63. doi: 10.1016/j.mehy.2012.02.004. Epub 2012 Mar 2.
8
Optimizing renal replacement therapy in older adults: a framework for making individualized decisions.优化老年患者的肾脏替代治疗:个体化决策框架。
Kidney Int. 2012 Aug;82(3):261-9. doi: 10.1038/ki.2011.384. Epub 2011 Nov 16.
9
Achieving fairness in access to kidney transplant: a work in progress.实现肾脏移植获取的公平性:一项正在进行的工作。
Am J Kidney Dis. 2011 Nov;58(5):697-9. doi: 10.1053/j.ajkd.2011.08.010.
10
Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant.目前被列入等待名单的60岁以上的肾移植候选者中,有一半会在接受尸体供体移植前死亡。
Clin J Am Soc Nephrol. 2009 Jul;4(7):1239-45. doi: 10.2215/CJN.01280209. Epub 2009 Jun 18.